Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC.

Lisovsky I, Kant S, Tremblay-McLean A, Isitman G, Kiani Z, Dupuy FP, Gilbert L, Bruneau J, Shoukry NH, Lebouché B, Bernard NF.

J Leukoc Biol. 2019 Jan 30. doi: 10.1002/JLB.4A0617-242RRR. [Epub ahead of print]

PMID:
30698860
2.

Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation.

Costiniuk CT, Saneei Z, Routy JP, Margolese S, Mandarino E, Singer J, Lebouché B, Cox J, Szabo J, Brouillette MJ, Klein MB, Chomont N, Jenabian MA.

BMJ Open. 2019 Jan 17;9(1):e024793. doi: 10.1136/bmjopen-2018-024793.

3.

Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study.

Costiniuk CT, Nitulescu R, Saneei Z, Wasef N, Salahuddin S, Wasef D, Young J, de Castro C, Routy JP, Lebouché B, Cox J, Smith BM, Ambroise S, Pexos C, Patel M, Szabo J, Haraoui LP, de Pokomandy A, Tsoukas C, Falutz J, LeBlanc R, Giannakis A, Frenette C, Jenabian MA, Bourbeau J, Klein MB.

HIV Med. 2019 Mar;20(3):192-201. doi: 10.1111/hiv.12699. Epub 2019 Jan 8.

PMID:
30620136
4.

Evaluation of a project to engage patients in the development of a patient-reported measure for HIV care (the I-Score Study).

Lessard D, Engler K, Toupin I; I-Score Consulting Team, Routy JP, Lebouché B.

Health Expect. 2018 Oct 29. doi: 10.1111/hex.12845. [Epub ahead of print]

PMID:
30375111
5.

Decision-making about motherhood among women living with HIV in Canada: a negotiation of multidimensional risks.

Toupin I, Engler K, Lebouché B, Otis J, Lévy JJ, Fernet M.

Cult Health Sex. 2018 Jul 11:1-15. doi: 10.1080/13691058.2018.1487585. [Epub ahead of print]

PMID:
29993351
6.

HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1.

Kiani Z, Dupuy FP, Bruneau J, Lebouché B, Zhang CX, Jackson E, Lisovsky I, da Fonseca S, Geraghty DE, Bernard NF.

J Immunol. 2018 Jul 1;201(1):113-123. doi: 10.4049/jimmunol.1701370. Epub 2018 May 9.

PMID:
29743316
7.

Barriers to antiretroviral therapy adherence in developed countries: a qualitative synthesis to develop a conceptual framework for a new patient-reported outcome measure.

Engler K, Lènàrt A, Lessard D, Toupin I, Lebouché B.

AIDS Care. 2018 Jan - Dec;30(sup1):17-28. doi: 10.1080/09540121.2018.1469725. Epub 2018 May 2.

PMID:
29719990
8.

Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review.

Kronfli N, Linthwaite B, Kouyoumdjian F, Klein MB, Lebouché B, Sebastiani G, Cox J.

Int J Drug Policy. 2018 Jul;57:95-103. doi: 10.1016/j.drugpo.2018.04.003. Epub 2018 Apr 30. Review.

PMID:
29715590
9.

Nasal Nitric Oxide Levels in HIV Infection: A Cross-Sectional Study.

Costiniuk CT, Mehraj V, Routy JP, de Castro C, Wasef N, Jenabian MA, Salahuddin S, Lebouché B, Cox J, Szabo J, Klein M, Lands L, Shapiro AJ.

AIDS Res Treat. 2018 Jan 9;2018:7645125. doi: 10.1155/2018/7645125. eCollection 2018.

10.

HIV-Positive Patients' Perceptions of Antiretroviral Therapy Adherence in Relation to Subjective Time: Imprinting, Domino Effects, and Future Shadowing.

Lessard D, Toupin I, Engler K, Lènàrt A; I-Score Consulting Team, Lebouché B.

J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325958218759208. doi: 10.1177/2325958218759208.

PMID:
29473484
11.

Socio-economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015.

Mehraj V, Cox J, Lebouché B, Costiniuk C, Cao W, Li T, Ponte R, Thomas R, Szabo J, Baril JG, Trottier B, Côté P, LeBlanc R, Bruneau J, Tremblay C, Routy JP; Montreal Primary HIV-Infection Study Group.

J Int AIDS Soc. 2018 Feb;21(2). doi: 10.1002/jia2.25034.

12.

Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection.

Benmassaoud A, Ghali P, Cox J, Wong P, Szabo J, Deschenes M, Osikowicz M, Lebouche B, Klein MB, Sebastiani G.

PLoS One. 2018 Jan 30;13(1):e0191985. doi: 10.1371/journal.pone.0191985. eCollection 2018.

13.

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.

Tan DHS, Hull MW, Yoong D, Tremblay C, O'Byrne P, Thomas R, Kille J, Baril JG, Cox J, Giguere P, Harris M, Hughes C, MacPherson P, O'Donnell S, Reimer J, Singh A, Barrett L, Bogoch I, Jollimore J, Lambert G, Lebouche B, Metz G, Rogers T, Shafran S; Biomedical HIV Prevention Working Group of the CIHR Canadian HIV Trials Network.

CMAJ. 2017 Nov 27;189(47):E1448-E1458. doi: 10.1503/cmaj.170494. No abstract available. Erratum in: CMAJ. 2018 Jun 25;190(25):E782.

14.

Decisional needs assessment of patients with complex care needs in primary care: a participatory systematic mixed studies review protocol.

Bujold M, Pluye P, Légaré F, Haggerty J, Gore GC, Sherif RE, Poitras ME, Beaulieu MC, Beaulieu MD, Bush PL, Couturier Y, Débarges B, Gagnon J, Giguère A, Grad R, Granikov V, Goulet S, Hudon C, Kremer B, Kröger E, Kudrina I, Lebouché B, Loignon C, Lussier MT, Martello C, Nguyen Q, Pratt R, Rihoux B, Rosenberg E, Samson I, Senn N, Li Tang D, Tsujimoto M, Vedel I, Ventelou B, Wensing M; Participatory Review Team.

BMJ Open. 2017 Nov 12;7(11):e016400. doi: 10.1136/bmjopen-2017-016400.

15.

The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research.

Mehraj V, Ghali P, Ramendra R, Costiniuk C, Lebouché B, Ponte R, Reinhard R, Sousa J, Chomont N, Cohen EA, Ancuta P, Routy JP.

J Virus Erad. 2017 Oct 1;3(4):212-217.

16.

Developing a patient-reported outcome measure for HIV care on perceived barriers to antiretroviral adherence: assessing the needs of HIV clinicians through qualitative analysis.

Toupin I, Engler K, Lessard D, Wong L, Lènàrt A, Spire B, Raffi F, Lebouché B.

Qual Life Res. 2018 Feb;27(2):379-388. doi: 10.1007/s11136-017-1711-5. Epub 2017 Oct 13.

PMID:
29027607
17.

Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells.

Tremblay-McLean A, Bruneau J, Lebouché B, Lisovsky I, Song R, Bernard NF.

Viruses. 2017 Oct 12;9(10). pii: E295. doi: 10.3390/v9100295.

18.

Patient profiles as organizing HIV clinicians' ART adherence management: a qualitative analysis.

Toupin I, Engler K, Lessard D, Wong L, Lènàrt A, Raffi F, Spire B, Lebouché B.

AIDS Care. 2018 Feb;30(2):207-210. doi: 10.1080/09540121.2017.1360995. Epub 2017 Aug 1.

PMID:
28764563
19.

Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.

Pembroke T, Deschenes M, Lebouché B, Benmassaoud A, Sewitch M, Ghali P, Wong P, Halme A, Vuille-Lessard E, Pexos C, Klein MB, Sebastiani G.

J Hepatol. 2017 Oct;67(4):801-808. doi: 10.1016/j.jhep.2017.05.011. Epub 2017 May 18.

PMID:
28527666
20.

Reevaluating Canada's policy for blood donations from men who have sex with men (MSM).

Jubran B, Billick M, Devlin G, Cygler J, Lebouché B.

J Public Health Policy. 2016 Dec;37(4):428-439. doi: 10.1057/s41271-016-0032-1.

PMID:
28202924
21.

Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients.

Vuille-Lessard É, Lebouché B, Lennox L, Routy JP, Costiniuk CT, Pexos C, Giannakis A, Szabo J, Klein MB, Sebastiani G.

AIDS. 2016 Nov 13;30(17):2635-2643.

PMID:
27603289
22.

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.

Isitman G, Tremblay-McLean A, Lisovsky I, Bruneau J, Lebouché B, Routy JP, Bernard NF.

PLoS One. 2016 Oct 12;11(10):e0164517. doi: 10.1371/journal.pone.0164517. eCollection 2016.

23.

A Review of HIV-Specific Patient-Reported Outcome Measures.

Engler K, Lessard D, Lebouché B.

Patient. 2017 Apr;10(2):187-202. doi: 10.1007/s40271-016-0195-7. Review.

PMID:
27637488
24.

The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection.

Lisovsky I, Isitman G, Tremblay-McLean A, Song R, DaFonseca S, Lebouchẻ B, Routy JP, Bruneau J, Bernard NF.

Clin Exp Immunol. 2016 Dec;186(3):336-346. doi: 10.1111/cei.12849. Epub 2016 Sep 9.

25.

The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection.

Mehraj V, Jenabian MA, Ponte R, Lebouché B, Costiniuk C, Thomas R, Baril JG, LeBlanc R, Cox J, Tremblay C, Routy JP; Montreal Primary HIV Infection, the Canadian Long-Term Non-Progressors Study Groups.

AIDS. 2016 Jun 19;30(10):1617-27. doi: 10.1097/QAD.0000000000001105.

26.

Evaluation of a Rapid Point of Care Test for Detecting Acute and Established HIV Infection, and Examining the Role of Study Quality on Diagnostic Accuracy: A Bayesian Meta-Analysis.

Smallwood M, Vijh R, Nauche B, Lebouché B, Joseph L, Pant Pai N.

PLoS One. 2016 Feb 18;11(2):e0149592. doi: 10.1371/journal.pone.0149592. eCollection 2016.

27.

Explaining the Presence of "Heterosexual" Female Clients of a Rapid HIV Testing Site Located in the Gay Village of Montreal, Quebec.

Engler K, Rollet K, Lessard D, Thomas R, Lebouché B.

J Prim Care Community Health. 2016 Apr;7(2):122-9. doi: 10.1177/2150131915626563. Epub 2016 Jan 20.

28.

Ability of a rapid HIV testing site to attract and test vulnerable populations: a cross-sectional study on Actuel sur Rue.

Engler K, Rollet K, Lessard D, Thomas R, Lebouché B.

Int J STD AIDS. 2016 Oct;27(11):973-7. doi: 10.1177/0956462415602420. Epub 2015 Sep 18.

PMID:
26384948
29.

Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.

Cao W, Mehraj V, Trottier B, Baril JG, Leblanc R, Lebouche B, Cox J, Tremblay C, Lu W, Singer J, Li T, Routy JP; Montreal Primary HIV Infection Study Group, Vézina S, Charest L, Milne M, Huchet E, Lavoie S, Friedman J, Duchastel M, Villielm F, Côté P, Potter M, Lessard B, Charron MA, Dufresne S, Turgeon ME, Rouleau D, Labrecque L, Fortin C, de Pokomandy A, Hal-Gagné V, Munoz M, Deligne B, Martel-Laferrière V, Gilmore N, Fletcher M, Szabo J.

Clin Infect Dis. 2016 Jan 15;62(2):250-257. doi: 10.1093/cid/civ809. Epub 2015 Sep 8.

30.

A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1.

Lisovsky I, Isitman G, Song R, DaFonseca S, Tremblay-McLean A, Lebouché B, Routy JP, Bruneau J, Bernard NF.

J Virol. 2015 Oct;89(19):9909-19. doi: 10.1128/JVI.01546-15. Epub 2015 Jul 22.

31.

Predictors of interest in taking pre-exposure prophylaxis among men who have sex with men who used a rapid HIV-testing site in Montreal (Actuel sur Rue).

Lebouché B, Engler K, Machouf N, Lessard D, Thomas R.

HIV Med. 2016 Feb;17(2):152-8. doi: 10.1111/hiv.12286. Epub 2015 Jul 14.

32.

Explaining the appeal for immigrant men who have sex with men of a community-based rapid HIV-testing site in Montreal (Actuel sur Rue).

Lessard D, Lebouché B, Engler K, Thomas R, Machouf N.

AIDS Care. 2015;27(9):1098-103. doi: 10.1080/09540121.2015.1028880. Epub 2015 Apr 7.

PMID:
25849524
33.

Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

Jenabian MA, El-Far M, Vyboh K, Kema I, Costiniuk CT, Thomas R, Baril JG, LeBlanc R, Kanagaratham C, Radzioch D, Allam O, Ahmad A, Lebouché B, Tremblay C, Ancuta P, Routy JP; Montreal Primary infection and Slow Progressor Study Groups.

J Infect Dis. 2015 Aug 1;212(3):355-66. doi: 10.1093/infdis/jiv037. Epub 2015 Jan 23.

PMID:
25616404
34.

Barriers to health-care and psychological distress among mothers living with HIV in Quebec (Canada).

Blais M, Fernet M, Proulx-Boucher K, Lebouché B, Rodrigue C, Lapointe N, Otis J, Samson J.

AIDS Care. 2015;27(6):731-8. doi: 10.1080/09540121.2014.997661. Epub 2015 Jan 14.

PMID:
25587793
35.

The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.

Lebouché B, Jenabian MA, Singer J, Graziani GM, Engler K, Trottier B, Thomas R, Brouillette MJ, Routy JP.

Trials. 2014 Oct 7;15:390. doi: 10.1186/1745-6215-15-390.

36.

Family quality of life in families affected by HIV: the perspective of HIV-positive mothers.

Blais M, Fernet M, Proulx-Boucher K, Lapointe N, Samson J, Otis J, Racicot C, Rodrigue C, Lebouché B.

AIDS Care. 2014;26 Suppl 1:S21-8. doi: 10.1080/09540121.2014.906551. Epub 2014 Apr 15.

PMID:
24735201
37.

HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.

Song R, Lisovsky I, Lebouché B, Routy JP, Bruneau J, Bernard NF.

PLoS Pathog. 2014 Jan;10(1):e1003867. doi: 10.1371/journal.ppat.1003867. Epub 2014 Jan 16.

38.

French HIV experts on early antiretroviral treatment for prevention: uncertainty and heterogeneity.

Lebouché B, Engler K, Lévy JJ, Gilmore N, Spire B, Rozenbaum W, Lacene T, Routy JP.

J Int Assoc Provid AIDS Care. 2014 Mar-Apr;13(2):160-9.

PMID:
23761218
39.

Minimal interference: A basis for selecting ART for prevention with positives.

Lebouché B, Engler K, Lévy JJ, Gilmore N, Spire B, Rozenbaum W, Routy JP.

AIDS Care. 2013;25(10):1284-90. doi: 10.1080/09540121.2013.764394. Epub 2013 Feb 11.

PMID:
23394079
40.

New directions in HIV healthcare.

Potter M, Lebouche B.

Expert Rev Anti Infect Ther. 2011 Jul;9(7):779-81. doi: 10.1586/eri.11.60.

PMID:
21810049
41.

Similar short-term efficacy of antiretroviral therapy in patients infected with HIV B and non-B subtype strains in france.

Bouchaud O, Le Moing V, Simon F, Ngo Van P, Perre P, Hocqueloux L, Lebouche B, Carret S, Spire B.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):e67-9. doi: 10.1097/QAI.0b013e31820206a2. No abstract available.

PMID:
21233637
42.

Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.

Miailhes P, Trabaud MA, Pradat P, Lebouché B, Chevallier M, Chevallier P, Zoulim F, Trepo C.

Clin Infect Dis. 2007 Sep 1;45(5):624-32. Epub 2007 Jul 30.

PMID:
17682999
43.

Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients.

Walter T, Lebouche B, Miailhes P, Cotte L, Roure C, Schlienger I, Trepo C.

Clin Infect Dis. 2006 Sep 15;43(6):787-90. Epub 2006 Aug 9. Erratum in: Clin Infect Dis. 2006 Dec 1;43(11):1498.

PMID:
16912958
44.

Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998.

Lebouché B, Yazdanpanah Y, Gérard Y, Sissoko D, Ajana F, Alcaraz I, Boitte P, Cadoré B, Mouton Y.

HIV Med. 2006 Apr;7(3):140-5.

45.

[Primary non-Hodgkin lymphoma of the liver in HIV infected patient: case-report].

Walter T, Béziat C, Miailhes P, Scalone O, Lebouché B, Trepo C.

Rev Med Interne. 2004 Aug;25(8):596-600. French.

PMID:
15276292

Supplemental Content

Loading ...
Support Center